Urinary protein

1 paper

Human trial1

Latest

4 in 12 months

Medicine9 Oct

Short-term clinical efficacy and recorded adverse events of semaglutide combined with dapagliflozin in patients with type 2 diabetes mellitus and chronic kidney disease

Cohort study of 126 peopleChronic kidney disease

Frontiers in Endocrinology18 Sep

Endocrine regulation of uromodulin in aging

ReviewMechanisms

Journal of Proteome Research4 Sep

Urine and Serum Proteome and Lipidome Analysis of Naturally Aging Feline Species

Experiments in catsMechanisms

Zhonghua Xin Xue Guan Bing Za Zhi13 Aug

Gastrointestinal metabolic surgery improves salt-sensitive hypertension via GLP-1-mediated inhibition of the RAS/NHE3 axis

Experiments in 48 ratsHypertension

The Lancet Diabetes & Endocrinology1 Jul

Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial

Randomised trial in 53 peopleSGLT2 inhibitors

Lancet19 Feb

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial

Randomised trial in 503 peoplemTOR inhibitors